Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3251 (-5.55%) ($0.3251 - $0.3251) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.13% (three month average) | RSI | 35 | Latest Price | $0.3251(-5.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -5.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -7.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PAVE(80%) EWP(70%) QQQ(69%) EWG(64%) SPY(62%) | Factors Impacting ANPC price | ANPC will decline at least -5.065% in a week (0% probabilities). SHY(-46%) BNDX(-34%) BND(-33%) TIP(-27%) VCSH(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.065% (StdDev 10.13%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.28(-6645.68%) | Resistance Level | $0.43 | 5 Day Moving Average | $0.37(-12.14%) | 10 Day Moving Average | $0.42(-22.6%) | 20 Day Moving Average | $0.43(-24.4%) | To recent high | -64.4% | To recent low | 0% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |